Cargando…
Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9
The CRISPR/Cas9 system is a powerful genome editing tool for the production of genetically modified animals. To produce mutant mice, chimeric single-guide RNA (sgRNA) is cloned in a plasmid vector and a mixture of sgRNA and Cas9 are microinjected into the fertilized eggs. An issue associated with ge...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Association for Laboratory Animal Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976241/ https://www.ncbi.nlm.nih.gov/pubmed/26972821 http://dx.doi.org/10.1538/expanim.15-0116 |
_version_ | 1782446836285440000 |
---|---|
author | Terao, Miho Tamano, Moe Hara, Satoshi Kato, Tomoko Kinoshita, Masato Takada, Shuji |
author_facet | Terao, Miho Tamano, Moe Hara, Satoshi Kato, Tomoko Kinoshita, Masato Takada, Shuji |
author_sort | Terao, Miho |
collection | PubMed |
description | The CRISPR/Cas9 system is a powerful genome editing tool for the production of genetically modified animals. To produce mutant mice, chimeric single-guide RNA (sgRNA) is cloned in a plasmid vector and a mixture of sgRNA and Cas9 are microinjected into the fertilized eggs. An issue associated with gene manipulation using the CRISPR/Cas9 system is that there can be off-target effects. To simplify the production of mutant mice with low risks of off-target effects caused by the CRISPR/Cas9 system, we demonstrated that genetically modified mice can be efficiently obtained using chemically synthesized CRISPR RNA (crRNA), trans-activating crRNA (tracrRNA), and modified Cas9s, such as the nickase version and FokI-fused catalytically inactive Cas9, by microinjection into fertilized eggs. Using this method, it is no longer necessary to clone sgRNA into a plasmid vector, and this enables high-throughput production of mutant mice. |
format | Online Article Text |
id | pubmed-4976241 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Japanese Association for Laboratory Animal Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-49762412016-08-09 Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9 Terao, Miho Tamano, Moe Hara, Satoshi Kato, Tomoko Kinoshita, Masato Takada, Shuji Exp Anim Original The CRISPR/Cas9 system is a powerful genome editing tool for the production of genetically modified animals. To produce mutant mice, chimeric single-guide RNA (sgRNA) is cloned in a plasmid vector and a mixture of sgRNA and Cas9 are microinjected into the fertilized eggs. An issue associated with gene manipulation using the CRISPR/Cas9 system is that there can be off-target effects. To simplify the production of mutant mice with low risks of off-target effects caused by the CRISPR/Cas9 system, we demonstrated that genetically modified mice can be efficiently obtained using chemically synthesized CRISPR RNA (crRNA), trans-activating crRNA (tracrRNA), and modified Cas9s, such as the nickase version and FokI-fused catalytically inactive Cas9, by microinjection into fertilized eggs. Using this method, it is no longer necessary to clone sgRNA into a plasmid vector, and this enables high-throughput production of mutant mice. Japanese Association for Laboratory Animal Science 2016-03-14 2016 /pmc/articles/PMC4976241/ /pubmed/26972821 http://dx.doi.org/10.1538/expanim.15-0116 Text en ©2016 Japanese Association for Laboratory Animal Science http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. |
spellingShingle | Original Terao, Miho Tamano, Moe Hara, Satoshi Kato, Tomoko Kinoshita, Masato Takada, Shuji Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9 |
title | Utilization of the CRISPR/Cas9 system for the efficient production of mutant
mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9 |
title_full | Utilization of the CRISPR/Cas9 system for the efficient production of mutant
mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9 |
title_fullStr | Utilization of the CRISPR/Cas9 system for the efficient production of mutant
mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9 |
title_full_unstemmed | Utilization of the CRISPR/Cas9 system for the efficient production of mutant
mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9 |
title_short | Utilization of the CRISPR/Cas9 system for the efficient production of mutant
mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9 |
title_sort | utilization of the crispr/cas9 system for the efficient production of mutant
mice using crrna/tracrrna with cas9 nickase and foki-dcas9 |
topic | Original |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976241/ https://www.ncbi.nlm.nih.gov/pubmed/26972821 http://dx.doi.org/10.1538/expanim.15-0116 |
work_keys_str_mv | AT teraomiho utilizationofthecrisprcas9systemfortheefficientproductionofmutantmiceusingcrrnatracrrnawithcas9nickaseandfokidcas9 AT tamanomoe utilizationofthecrisprcas9systemfortheefficientproductionofmutantmiceusingcrrnatracrrnawithcas9nickaseandfokidcas9 AT harasatoshi utilizationofthecrisprcas9systemfortheefficientproductionofmutantmiceusingcrrnatracrrnawithcas9nickaseandfokidcas9 AT katotomoko utilizationofthecrisprcas9systemfortheefficientproductionofmutantmiceusingcrrnatracrrnawithcas9nickaseandfokidcas9 AT kinoshitamasato utilizationofthecrisprcas9systemfortheefficientproductionofmutantmiceusingcrrnatracrrnawithcas9nickaseandfokidcas9 AT takadashuji utilizationofthecrisprcas9systemfortheefficientproductionofmutantmiceusingcrrnatracrrnawithcas9nickaseandfokidcas9 |